Literature DB >> 25147597

Stabilized helical peptides: a strategy to target protein-protein interactions.

Mark A Klein1.   

Abstract

Protein-protein interactions are critical for cell proliferation, differentiation, and function. Peptides hold great promise for clinical applications focused on targeting protein-protein interactions. Advantages of peptides include a large chemical space and potential diversity of sequences and structures. However, peptides do present well-known challenges for drug development. Progress has been made in the development of stabilizing alpha helices for potential therapeutic applications. Advantages and disadvantages of different methods of helical peptide stabilization are discussed.

Keywords:  protein−protein interactions; stabilized peptide; α helix

Year:  2014        PMID: 25147597      PMCID: PMC4137361          DOI: 10.1021/ml500235d

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  9 in total

Review 1.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

Authors:  C A Lipinski; F Lombardo; B W Dominy; P J Feeney
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

Review 2.  Targeting protein-protein interactions by rational design: mimicry of protein surfaces.

Authors:  Steven Fletcher; Andrew D Hamilton
Journal:  J R Soc Interface       Date:  2006-04-22       Impact factor: 4.118

3.  Evaluation of biologically relevant short alpha-helices stabilized by a main-chain hydrogen-bond surrogate.

Authors:  Deyun Wang; Kang Chen; John L Kulp Iii; Paramjit S Arora
Journal:  J Am Chem Soc       Date:  2006-07-19       Impact factor: 15.419

4.  Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome.

Authors:  J Rubin; J Ajani; W Schirmer; A P Venook; R Bukowski; R Pommier; L Saltz; P Dandona; L Anthony
Journal:  J Clin Oncol       Date:  1999-02       Impact factor: 44.544

5.  Evaluation of diverse α/β-backbone patterns for functional α-helix mimicry: analogues of the Bim BH3 domain.

Authors:  Melissa D Boersma; Holly S Haase; Kimberly J Peterson-Kaufman; Erinna F Lee; Oliver B Clarke; Peter M Colman; Brian J Smith; W Seth Horne; W Douglas Fairlie; Samuel H Gellman
Journal:  J Am Chem Soc       Date:  2011-12-08       Impact factor: 15.419

6.  Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.

Authors:  Hagop Kantarjian; Charles Sawyers; Andreas Hochhaus; Francois Guilhot; Charles Schiffer; Carlo Gambacorti-Passerini; Dietger Niederwieser; Debra Resta; Renaud Capdeville; Ulrike Zoellner; Moshe Talpaz; Brian Druker; John Goldman; Stephen G O'Brien; Nigel Russell; Thomas Fischer; Oliver Ottmann; Pascale Cony-Makhoul; Thierry Facon; Richard Stone; Carole Miller; Martin Tallman; Randy Brown; Michael Schuster; Thomas Loughran; Alois Gratwohl; Franco Mandelli; Giuseppe Saglio; Mario Lazzarino; Domenico Russo; Michele Baccarani; Enrica Morra
Journal:  N Engl J Med       Date:  2002-02-28       Impact factor: 91.245

7.  Estimating the size of the human interactome.

Authors:  Michael P H Stumpf; Thomas Thorne; Eric de Silva; Ronald Stewart; Hyeong Jun An; Michael Lappe; Carsten Wiuf
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-12       Impact factor: 11.205

Review 8.  Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy.

Authors:  Min H Kang; C Patrick Reynolds
Journal:  Clin Cancer Res       Date:  2009-02-15       Impact factor: 12.531

Review 9.  Hydrocarbon-stapled peptides: principles, practice, and progress.

Authors:  Loren D Walensky; Gregory H Bird
Journal:  J Med Chem       Date:  2014-03-06       Impact factor: 7.446

  9 in total
  5 in total

1.  Functional inhibition of c-Myc using novel inhibitors identified through "hot spot" targeting.

Authors:  Ashutosh Singh; Prateek Kumar; Sailu Sarvagalla; Taniya Bharadwaj; Namyashree Nayak; Mohane Selvaraj Coumar; Rajanish Giri; Neha Garg
Journal:  J Biol Chem       Date:  2022-04-01       Impact factor: 5.486

2.  Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection.

Authors:  Philippe Karoyan; Vincent Vieillard; Luis Gómez-Morales; Estelle Odile; Amélie Guihot; Charles-Edouard Luyt; Alexis Denis; Pascal Grondin; Olivier Lequin
Journal:  Commun Biol       Date:  2021-02-12

3.  Double Strain-Promoted Macrocyclization for the Rapid Selection of Cell-Active Stapled Peptides.

Authors:  Yu Heng Lau; Yuteng Wu; Maxim Rossmann; Ban Xiong Tan; Peterson de Andrade; Yaw Sing Tan; Chandra Verma; Grahame J McKenzie; Ashok R Venkitaraman; Marko Hyvönen; David R Spring
Journal:  Angew Chem Int Ed Engl       Date:  2015-11-02       Impact factor: 15.336

4.  A New Methodology for Incorporating Chiral Linkers into Stapled Peptides.

Authors:  Juan C Serrano; James Sipthorp; Wenshu Xu; Laura S Itzhaki; Steven V Ley
Journal:  Chembiochem       Date:  2017-05-18       Impact factor: 3.461

5.  Rational design of a helical peptide inhibitor targeting c-Myb-KIX interaction.

Authors:  Shunji Suetaka; Yoshiki Oka; Tomoko Kunihara; Yuuki Hayashi; Munehito Arai
Journal:  Sci Rep       Date:  2022-01-20       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.